1. United States Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

1.85
EUR
-0.05
(-2.63%)
-2.09EPS
67.12MMarket Cap
Nov 11Next Earn

Latest Stock Split

Apr 22, 2025

1:20

For every 20 shares held, investors received 1.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data
Stock Splits APIChatGPT

Stock Split History

  1. Apr 22, 2025
    Before—
    Split ratio1:20
    After—
    Reverse

About Seres Therapeutics, Inc. stock splits

Seres Therapeutics, Inc. (GETTEX:1S90) operates in the Biotechnology industry.

Seres Therapeutics, Inc. company overview

When did Seres Therapeutics, Inc. stock split?

Seres Therapeutics, Inc.'s most recent stock split was on April 22, 2025. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.

How many times has Seres Therapeutics, Inc. stock split?

Seres Therapeutics, Inc. has split its stock once. This history records one reverse split, on April 22, 2025.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Seres Therapeutics, Inc.'s 1-for-20 reverse split on April 22, 2025, every 20 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Seres Therapeutics, Inc. split its stock again?

Seres Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on April 22, 2025, 1 year ago. Companies announce splits in advance, and any new GETTEX:1S90 split will appear on this page.